3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Solid Tumors
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharangeal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lung Neoplasms
1
Kidney Neoplasms
1
Kidney Diseases
1
Hemangiosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
CRC
1
Interventions
Cyclophosphamide
3
Gemcitabine
2
regorafenib
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Restraint, Physical
1
Range of Motion, Articular
1
Quality of Life
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Metastasectomy
1
Masks
1
Lomustine
1
Irinotecan
1
Ipilimumab
1
Everolimus
1
Etoposide
1
Doxorubicin
1
Data Collection
1
Cisplatin
1
Carboplatin
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
spartalizumab
×
90 days
×
Clear all
No trials found.